Software Effective Solutions Corp. (SFWJ) Dedicated to Becoming Leader in Growing Cannabis Sector
- A recent report projects that the cannabis market, which totaled an estimated $27.7 billion in 2022, will reach $82.3 billion by 2027
- The forecast includes businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products
- MedCana is building technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world
With the worldwide cannabis market projected to see a compound annual growth rate (“CAGR”) of 24.3% in the next three years, Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is committed to strengthening its foothold in the growing space. The company, which is committed to being a global force for better cannabis products, is determined to be the world’s premier resource for pharmaceutical cannabis products.
“The cannabis market is estimated at $27.7 billion in 2022 and is projected to reach $82.3 billion by 2027, at a CAGR of 24.3%,” reported a MarketsandMarkets article earlier this year (https://nnw.fm/MFc3d ). “In recent years, the cannabis industry has experienced significant growth and expansion, driven by increasing legalization efforts in various parts of the world, shifting public attitudes towards cannabis use and recognition of its potential medicinal benefits. This growth has led to the emergence of a diverse range of companies, including large-scale producers, dispensaries, manufacturers of cannabis-derived pharmaceuticals, technology firms developing innovative cultivation and extraction methods, and ancillary businesses providing services such as packaging, branding, and legal support.”
Noting that the term “cannabis industry” refers to the collection of businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products, the article outlines several factors likely to contribute to the sector’s growth, including legalization efforts, product innovation, investment and M&A activity, and the regulatory landscape.
The article also noted that “the medical cannabis segment is expected to continue growing, driven by increasing recognition of cannabis’s therapeutic properties and its potential to treat various medical conditions. Pharmaceutical companies are also investing in cannabis-based medications, contributing to market expansion.” In addition, “The recreational cannabis market is [also] forecasted to see continued growth, particularly in regions where legalization has occurred or is expected. Changing attitudes towards cannabis use and increasing consumer acceptance are key drivers in this segment.”
These factors all point to a promising cannabis sector moving forward, with MedCana committed to doing the work necessary to become a leader in the space. The company is building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world, all with absolute integrity, sustainability and social responsibility (https://nnw.fm/yULBU ).
MedCana is a global infrastructure and holding company in the cannabis industry. The company currently has five divisions focused on pharmaceutical cannabis production, as well a software division focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology division has rounded out MedCana’s portfolio of holdings.
For more information, visit the company’s website at www.MedCana.net.
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://nnw.fm/SFWJ
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
- A recent report projects that the cannabis market, which totaled an estimated $27.7 billion in 2022, will reach $82.3 billion by 2027
- The forecast includes businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products
- MedCana is building technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world
With the worldwide cannabis market projected to see a compound annual growth rate (“CAGR”) of 24.3% in the next three years, Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is committed to strengthening its foothold in the growing space. The company, which is committed to being a global force for better cannabis products, is determined to be the world’s premier resource for pharmaceutical cannabis products.
“The cannabis market is estimated at $27.7 billion in 2022 and is projected to reach $82.3 billion by 2027, at a CAGR of 24.3%,” reported a MarketsandMarkets article earlier this year (https://nnw.fm/MFc3d ). “In recent years, the cannabis industry has experienced significant growth and expansion, driven by increasing legalization efforts in various parts of the world, shifting public attitudes towards cannabis use and recognition of its potential medicinal benefits. This growth has led to the emergence of a diverse range of companies, including large-scale producers, dispensaries, manufacturers of cannabis-derived pharmaceuticals, technology firms developing innovative cultivation and extraction methods, and ancillary businesses providing services such as packaging, branding, and legal support.”
Noting that the term “cannabis industry” refers to the collection of businesses and enterprises involved in the cultivation, processing, distribution and sale of cannabis and cannabis-related products, the article outlines several factors likely to contribute to the sector’s growth, including legalization efforts, product innovation, investment and M&A activity, and the regulatory landscape.
The article also noted that “the medical cannabis segment is expected to continue growing, driven by increasing recognition of cannabis’s therapeutic properties and its potential to treat various medical conditions. Pharmaceutical companies are also investing in cannabis-based medications, contributing to market expansion.” In addition, “The recreational cannabis market is [also] forecasted to see continued growth, particularly in regions where legalization has occurred or is expected. Changing attitudes towards cannabis use and increasing consumer acceptance are key drivers in this segment.”
These factors all point to a promising cannabis sector moving forward, with MedCana committed to doing the work necessary to become a leader in the space. The company is building the technology, laboratories, growing facilities and scientific teams needed to provide premium pharmaceutical-grade cannabis extracts to the world, all with absolute integrity, sustainability and social responsibility (https://nnw.fm/yULBU ).
MedCana is a global infrastructure and holding company in the cannabis industry. The company currently has five divisions focused on pharmaceutical cannabis production, as well a software division focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology division has rounded out MedCana’s portfolio of holdings.
For more information, visit the company’s website at www.MedCana.net.
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://nnw.fm/SFWJ
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
